These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17470211)

  • 1. Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants.
    Meuris B; Arnout J; Vlasselaers D; Schetz M; Meyns B
    Artif Organs; 2007 May; 31(5):402-5. PubMed ID: 17470211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Steinlechner B; Rajek A; Schima H; Wolner E; Wieselthaler GM
    Artif Organs; 2008 Oct; 32(10):819-22. PubMed ID: 18959671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
    Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
    J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device.
    Ghez O; Liesner R; Karimova A; Ng C; Goldman A; van Doorn C
    ASAIO J; 2006; 52(6):705-7. PubMed ID: 17117062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First clinical experience with the Incor left ventricular assist device.
    Schmid C; Tjan TD; Etz C; Schmidt C; Wenzelburger F; Wilhelm M; Rothenburger M; Drees G; Scheld HH
    J Heart Lung Transplant; 2005 Sep; 24(9):1188-94. PubMed ID: 16143232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of low-molecular-weight heparin to bridge therapy in obese patients and in patients with renal dysfunction.
    George-Phillips KL; Bungard TJ
    Pharmacotherapy; 2006 Oct; 26(10):1479-90. PubMed ID: 16999658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of platelet function during left ventricular support with the Incor and Excor system.
    Etz C; Welp H; Rothenburger M; Tjan TD; Wenzelburger F; Schmidt C; Scheld HH; Schmid C
    Heart Surg Forum; 2004; 7(5):E423-7. PubMed ID: 15799917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for anticoagulation of children on mechanical circulatory support.
    Copeland H; Nolan PE; Covington D; Gustafson M; Smith R; Copeland JG
    Artif Organs; 2011 Nov; 35(11):1018-23. PubMed ID: 22097979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary single center North American experience with the Berlin Heart pediatric EXCOR device.
    Rockett SR; Bryant JC; Morrow WR; Frazier EA; Fiser WP; McKamie WA; Johnson CE; Chipman CW; Imamura M; Jaquiss RD
    ASAIO J; 2008; 54(5):479-82. PubMed ID: 18812737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
    Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
    Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of platelet inhibitors on thromboembolism after implantation of a Novacor N100--preliminary results.
    Schmid C; Weyand M; Hammel D; Deng MC; Nabavi D; Scheld HH
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):260-2. PubMed ID: 9885115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system.
    Morshuis M; El-Banayosy A; Arusoglu L; Koerfer R; Hetzer R; Wieselthaler G; Pavie A; Nojiri C
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1020-7; discussion 1027-8. PubMed ID: 19233673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumatic paracorporeal ventricular assist device in infants and children: initial Stanford experience.
    Malaisrie SC; Pelletier MP; Yun JJ; Sharma K; Timek TA; Rosenthal DN; Wright GE; Robbins RC; Reitz BA
    J Heart Lung Transplant; 2008 Feb; 27(2):173-7. PubMed ID: 18267223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HeartMate II left ventricular assist device; early European experience.
    Strüber M; Sander K; Lahpor J; Ahn H; Litzler PY; Drakos SG; Musumeci F; Schlensak C; Friedrich I; Gustafsson R; Oertel F; Leprince P
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):289-94. PubMed ID: 18571932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.